Valve Disease. Valve Surgery. In 2015, Cleveland Clinic surgeons performed 2943 valve surgeries.

Similar documents
Valve Disease. Valve Surgery. Total Volume. In 2016, Cleveland Clinic surgeons performed 3039 valve surgeries.

Ischemic Heart Disease Interventional Treatment

Ischemic Heart Disease Interventional Treatment

Policy Specific Section: March 30, 2012 March 7, 2013

Mechanical vs. Bioprosthetic Aortic Valve Replacement: Time to Reconsider? Christian Shults, MD Cardiac Surgeon, Medstar Heart and Vascular Institute

In 2015, Cleveland Clinic surgeons performed 1551 thoracic procedures. The in-hospital mortality rate was 2.1%. 20% airway (N = 315)

After PARTNER 2A/S3i and SURTAVI: What is the Role of Surgery in Intermediate-Risk AS Patients?

Peripheral Vascular Disease

In Process, Unpublished STS/ACC TVT Registry Manuscripts

In Process, Unpublished STS/ACC TVT Registry Manuscripts

Aortic Disease. Aortic Surgery

Valvular Intervention

Valvular Heart Disease Transcatheter Valve Therapies. October 2016 Brian Whisenant MD

Outcomes in the Commercial Use of Self-expanding Prostheses in Transcatheter Aortic Valve Replacement: A Comparison of the Medtronic CoreValve and

Transcatheter Valve Replacement: Current State in 2017

Appropriate Patient Selection or Healthcare Rationing? Lessons from Surgical Aortic Valve Replacement in The PARTNER I Trial Wilson Y.

Contemporary outcomes for surgical mitral valve repair: A benchmark for evaluating emerging mitral valve technology

THE VALVE CLINIC VALVE CONFERENCE

Sotirios N. Prapas, M.D., Ph.D, F.E.C.T.S.

MitraClip: Why, How, and For Whom?

MINIMALLY INVASIVE MITRAL VALVE SURGERY. Rohinton J. Morris, MD Chief, Cardiothoracic Surgery Jefferson University and Health Systems

Is a minimally invasive approach for re-operative aortic valve replacement superior to standard full resternotomy?

Hardware in the Chest - From VADs to Valves

Extension to medium and low risk patients? Friedrich Eckstein University Hospital Basel

CIPG Transcatheter Aortic Valve Replacement- When Is Less, More?

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

Heart & Vascular Institute Outcomes

Tissue vs Mechanical What s the Data??

Objectives. Describe a multidisciplinary team and it s utilization in the inpatient cardiovascular surgical patient

TAVI and TAVR: Radical and Revolutionary: The Newest Insights for the CV Community and a Panel Discussion

What is the Role of Surgical Repair in 2012

2016 Physician Quality Reporting System Data Collection Form: Coronary Artery Bypass Graft (CABG) (for patients aged 18 years and older)

Kinsing Ko, Thom de Kroon, Najim Kaoui, Bart van Putte, Nabil Saouti. St. Antonius Hospital, Nieuwegein, The Netherlands

mm Porcine valve Patient had requested

Index. Note: Page numbers of article titles are in boldface type.

Surgeon Involvement in Transcatheter Valve Therapy

The Ross Procedure: Outcomes at 20 Years

Mitral Valve Surgery: Lessons from New York State

Transcatheter Therapies For Aortic Valve Disease. March 2017 Brian Whisenant MD

Debate: SAVR for Low-Risk Patients in 2017 is Obsolete AVR vs TAVI

TAVR and Cardiac Surgeons

Late failure of transcatheter heart valves: An open question

7 th Conference of Transcatheter Heart Valve Therapies

THE NATIONAL QUALITY FORUM

2/15/2018 DISCLOSURES OBJECTIVES. Consultant for BioSense Webster, a J&J Co. Aortic stenosis background. Short history of TAVR

New Paradigms in Thoracic. Accommodate Advances in Cardiovascular Surgical Therapy. A.J. Carpenter, MD, PhD Professor of Thoracic Surgery

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

Valvular Heart Disease and Adult Congenital Intervention. A Pichard, MD. Director Cath Labs, Washington Hospital Center. Georgetown University.

Igor Palacios, MD Director of Interventional Cardiology Massachusetts General Hospital Professor of Medicine Harvard Medical School

DESCRIPTION: Percentage of patients aged 18 years and older undergoing isolated CABG surgery who received an IMA graft

Bicuspid aortic root spared during ascending aorta surgery: an update of long-term results

Measure #167 (NQF 0114): Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure National Quality Strategy Domain: Effective Clinical Care

Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea

Strokes After TAVR Reasons for Declining Frequency

Aortic Valve Stenosis and TAVR: Putting it all together.

Percutaneous Transapical Access for Thoracic Endovascular Repair

Published Manuscripts Based in the STS/ACC TVT Registry

Alec Vahanian,FESC, FRCP (Edin.) Bichat Hospital University Paris VII, Paris, France

TAVR Transaortic Approach: New Trends in Aortic Valve Surgery

Is TAVR Now Indicated in Even Low Risk Aortic Valve Disease Patients

In 2015, Cleveland Clinic cardiac and vascular

Quality Measures MIPS CV Specific

Transcatheter Aortic Valve Replacement

Should We Reconsider using Anticoagulation for Biological Tissue Valves

Evolving and Expanding Indications for TAVR

Cardiac Valve/Structural Therapies

Quality ID #168 (NQF 0115): Coronary Artery Bypass Graft (CABG): Surgical Re-Exploration National Quality Strategy Domain: Effective Clinical Care

TAVR in 2020: What is Next!!!!

Indication, Timing, Assessment and Update on TAVI

TAVR for Valve-In-Valve. Brian O Neill Assistant Professor of Medicine Department of Medicine, Section of Cardiology

Aortic Stenosis: Open vs TAVR vs Nothing

TAVR IN INTERMEDIATE-RISK PATIENTS

Published Manuscripts Based in the STS/ACC TVT Registry

YOUR CARDIOTHORACIC SURGERY TEAM

Valvular heart disease (VHD) is present in 2.5% of the

Steph ani eph ani Mi M ck i MD Cleveland Clinic

How to Avoid Prosthesis-Patient Mismatch

ACTION REGISTRY New Old ID# ID #

Percutaneous Aortic Valvuloplasty: Long-Term Survival

Expanding Relevance of Aortic Valve Repair Is Earlier Operation Indicated?

Aortic Stenosis: Background

When Should We Consider TAVI. (Surgeon s Viewpoint)? Pyowon Park Samsung Medical Center Seoul, Korea

Valvular Heart Disease:

Measure #164 (NQF 0129): Coronary Artery Bypass Graft (CABG): Prolonged Intubation National Quality Strategy Domain: Effective Clinical Care

Outcomes of Surgical Aortic Valve Replacement in Moderate Risk Patients: Implications for Determination of Equipoise in the Transcatheter Era

Understanding the guidelines for Interventions in MR. Ali AlMasood

Cleveland Clinic Innovation Center

TAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair?

University of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives

YOUR CARDIOTHORACIC SURGERY TEAM

Essential Support for a Structural Heart Program: The Valve and Structural Heart Clinic

Is Stroke Frequency Declining?

Selection of aortic valve replacement versus transcatheter aortic valve replacement in high-risk patients: a Markov model

Percutaneous Valve in Native With and Without Mitral Valve Calcification: When To Go Hybrid

Carpentier-Edwards Pericardial Valve in the Aortic Position: 25-Years Experience

Incorporating the intermediate risk in Transcatheter Aortic Valve Implantation (TAVI)

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat

Peripheral and Cardiology Coder 2018

Next Generation Therapies: Aortic, Mitral and Beyond

Culprit vs Multivalve Transcatheter Intervention

Transcription:

Valve Surgery 11 15 Volume 3 1 11 1 13 1 N = 1 773 5 79 15 93 In 15, surgeons performed 93 valve surgeries. surgeons have implanted more than 1,5 bioprosthetic aortic valves since the 199s, with excellent short- and long-term outcomes. Outcomes 15

Primary Operation and Reoperation Volume (N = 93) 15 Volume 5 15 1 5 Primary Operation Reoperation surgeons performed 93 valve procedures in 15. A total of 199 were primary operations and 7 were reoperations (5%). Primary Operation and Reoperation In-Hospital Mortality (N = 93) 15 Primary Operation Reoperation Patients who have valve surgery reoperations have a somewhat higher risk of death compared with patients who have a primary operation, due to the overall decrease in health over time. Despite this, the in-hospital mortality rates were lower than expected for both reoperations and primary procedures. Source: Data from the Vizient Clinical Data Base/Resource Manager TM used by permission of Vizient. All rights reserved. Sydell and Arnold Miller Family Heart & Vascular Institute 9

In-Hospital Mortality by Type (N = 93) 15 1 1 Surgical Isolated AVR Transcatheter AVR AVR + CABG % Isolated MVR % % MVR + CABG Isolated MV Repair Septal Myectomy a N = 33 1 9 3 193 STS expected The 15 in-hospital mortality rates for all types of valve surgery at were lower than expected. AVR = aortic valve replacement, CABG = coronary artery bypass grafting, MV = mitral valve, MVR = mitral valve replacement a These valve surgery cases do not have established STS expected mortality rates due to the complexity of the procedures. Source: Society of Thoracic Surgeons (STS) National Adult Cardiac Surgery Database 15 Aortic Valve Surgery 11 15 Volume 15 In 15, 193 aortic valve procedures were performed at. 1 5 N = 11 1753 1 193 13 1 175 17 15 193 3 Outcomes 15 3

STS Rating for Aortic Valve Replacement June 1 June 15 ranked among the top % of US hospitals for aortic valve replacement (AVR) surgery, earning the Society of Thoracic Surgeons (STS) 3-star rating for this category. This denotes the highest category of quality. Participant Score (95% Confidence Interval) STS Mean Participant Score Participant Rating 97.% 9.7% (9., 97.9) STS Min.3 1th 9.1 5th 95.1 9th 97. Max 9.5 = STS mean participant score Source: Society of Thoracic Surgeons (STS) National Adult Cardiac Surgery Database 15 Isolated Aortic Valve Replacement Complications (N = ) 15 1 STS expected % Deep Sternal Wound Infection Postop Stroke Postop Renal Failure Postop Reoperation (Any) had lower-than-expected rates of complications for isolated aortic valve replacement surgery. Source: Society of Thoracic Surgeons (STS) National Adult Cardiac Surgery Database 15 Sydell and Arnold Miller Family Heart & Vascular Institute 31

STS Rating for Coronary Artery Bypass Grafting and Aortic Valve Replacement June 1 June 15 ranked among the top.3% of US hospitals for coronary artery bypass graft (CABG) surgery plus aortic valve replacement (AVR), earning the Society of Thoracic Surgeons (STS) 3-star rating for this category (based on data from July 1 through June 15). This denotes the highest category of quality. Participant Score (95% Confidence Interval) STS Mean Participant Score Participant Rating 95.5% 91.7% (9., 9.3) STS Min 79. 1th.3 5th 9.1 9th 9.7 Max 97.1 = STS mean participant score Source: Society of Thoracic Surgeons (STS) National Adult Cardiac Surgery Database 15 Combined Coronary Artery Bypass Grafting and Aortic Valve Replacement In-Hospital Mortality (N = 1) 15 1 N = Primary Operation 1 Reoperation 3 STS expected Source: Society of Thoracic Surgeons (STS) National Adult Cardiac Surgery Database 15 Aortic valve replacement, in combination with coronary artery bypass graft (CABG) surgery, is a complex operation. Despite this complexity and the associated increase in risks, in-hospital mortality rates for both primary operations and reoperations were low. 3 Outcomes 15

Mitral Valve Surgery Volume, Repair vs Replacement 11 15 11 1 13 1 15 Repair Replacement performs mitral valve repair procedures rather than replacement whenever possible. Mitral valve repair is associated with better survival, improved lifestyle, better preservation of heart function, and a lower risk of stroke and infection (endocarditis) compared with mitral valve replacement. Repair procedures also do not require postprocedure anticoagulation therapy. Isolated Mitral Valve Surgery In-Hospital Mortality (N = 13) 15 STS expected The 15 in-hospital mortality rates for patients who had isolated mitral valve surgery were lower than expected for both repair and replacement procedures. % Replacement Repair N = 9 3 Source: Society of Thoracic Surgeons (STS) National Adult Cardiac Surgery Database 15 As world leaders in mitral valve repairs, surgeons performed robotically assisted mitral valve surgery on 1 patients from to 1. The mortality rate was.1% (N = 1). Source: Gillinov AM, Mihaljevic T, Javadikasgari H, Suri R, Mick S, Navia J, Desai M, Bonatti J, Khosravi M, Idrees J, Lowry A, Blackstone E, Svensson L. Safety and Effectiveness of Robotically Assisted Mitral Valve Surgery: Analysis of 1, Consecutive Cases. Paper presented at: American Association for Thoracic Surgery Annual Meeting; May 1-1, 1. Baltimore, MD. Sydell and Arnold Miller Family Heart & Vascular Institute 33

Surgical Treatment of Active Infective Endocarditis Primary Operation, In-Hospital Mortality 13 15 15 1 Observed The in-hospital mortality rates for patients who had primary operations for infective endocarditis were lower than expected in 15. 5 N = % 13 1 15 59 59 Source: Data from the Vizient Clinical Data Base/Resource Manager TM used by permission of Vizient. All rights reserved. Reoperation, In-Hospital Mortality 13 15 15 1 Observed The in-hospital mortality rates for patients who had reoperations for infective endocarditis were lower than expected in 15. 5 N = 13 1 1 15 9 9 Source: Data from the Vizient Clinical Data Base/Resource Manager TM used by permission of Vizient. All rights reserved. 3 Outcomes 15

Transcatheter Aortic Valve Replacement is a national leader in the use of percutaneous treatment options for patients with valve disease. Volume and In-Hospital Mortality 11 15 Volume 35 3 5 15 1 5 11 1 13 N = 15 15 17 1 33 15 33 Mortality (%) 1 1 Observed 11 1 13 1 15 N = 15 15 17 33 33 A total of 33 patients had transcatheter aortic valve replacement (TAVR) procedures at in 15. The in-hospital mortality rate was.3% compared with an expected rate of 7.%. Source: Data from the Vizient Clinical Data Base/Resource Manager TM used by permission of Vizient. All rights reserved. Since the inception of the transcatheter aortic valve replacement (TAVR) program in, has become a world leader in the use of this specialized treatment in patients carefully selected based upon stringent clinical criteria. A total of 1 patients have had this procedure done from 1 to 15, and the in-hospital mortality rate was 1.7% compared with the expected rate of 7.7%. Source: STS/ACC TVT Registry Sydell and Arnold Miller Family Heart & Vascular Institute 35

In-Hospital Mortality (N = 1) 1 15 began its transcatheter aortic valve replacement (TAVR) program in. From 1 to 15, 1 TAVR procedures have been performed with a lower-than-expected mortality rate (1.7% vs 7.7%). Source: Society of Thoracic Surgeons (STS)/American College of Cardiology (ACC) Transcatheter Valve Therapy (TVT) Registry Volume by Approach (N = 75) 1 15 Of the 75 TAVR procedures performed from 1 through 15, 73% have been done using a transfemoral approach. 1% 73% transfemoral (N = 39) 17% transapical (N = 1) 7% transaortic (N = 3) % other (transaxillary, transcarotid) (N = 15) 1% subclavian (N = 1) 3 Outcomes 15